Moreover, RT can counteract tumor immune evasion by upregulating MHC class 1 molecules on the surface of tumor cells and by modulating their peptide repertoire, allowing tumor cell recognition by cytotoxic CD8 T cells [20,21]. This evidence concerns the gene CD8A and neoplasm.